Obesity and cardiovascular disease in women

Camila Manrique-Acevedo1,2,3, Bhavana Chinnakotla1, Jaume Padilla3,4

  • 1Division of Endocrinology and Metabolism, Department of Medicine, University of Missouri, Columbia, MO, USA.

Insights

Obesity increases cardiovascular disease (CVD) risk, especially in women. This review explores how obesity uniquely impacts women

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Women's Health

Background:

  • Rising global obesity rates contribute to a significant health and financial burden from related comorbidities.
  • Cardiovascular disease (CVD) is strongly linked to increased adiposity, with women facing a disproportionately higher risk.
  • Obese women, particularly those with insulin resistance, exhibit elevated risks for heart failure with preserved ejection fraction and ischemic heart disease.

Purpose of the Study:

  • To review evidence on the differential cardiovascular impact of adiposity in women versus men.
  • To explore proposed pathophysiological mechanisms underlying these sex-specific differences.
  • To discuss women-specific risk factors for CVD in the context of obesity and insulin resistance.

Main Methods:

  • Literature review of existing evidence.
  • Analysis of proposed pathophysiological mechanisms.
  • Discussion of epidemiological data and clinical observations.

Main Results:

  • Obesity presents unique cardiovascular risks for women, differing from those in men.
  • Mechanisms include altered aldosterone, mineralocorticoid receptor activation, estrogenic signaling, and androgen levels.
  • Women-specific factors like pregnancy weight gain, preeclampsia, gestational diabetes, and menopause exacerbate CVD risk.

Conclusions:

  • Understanding sex-specific impacts of obesity on cardiovascular health is crucial.
  • Targeted interventions considering women's unique risk factors are needed to combat the CVD epidemic.
  • Further research into the mechanisms driving differential CVD risk in obese women is warranted.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
797
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
166
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
190
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
290
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
128